Breast cancer epidemiology, prevention, and early detection

Current Opinion in Oncology

Volumn 13, Issue 6, 2001, Pages 420-425

  Brewster, Abenaa ^a   Helzlsouer, Kathy ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ESTROGEN; ORAL CONTRACEPTIVE AGENT; VITAMIN;

ALCOHOL CONSUMPTION; ANTHROPOMETRY; BREAST CANCER; BREAST DISEASE; BREAST EXAMINATION; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; DIET; FAT INTAKE; FEMALE; GENE MUTATION; HEREDITY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PHYSICAL ACTIVITY; PRIMARY PREVENTION; PRIORITY JOURNAL; REPRODUCTION; REVIEW;

BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CLINICAL TRIALS; DIET; ESTROGENS; EXERCISE; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MAMMOGRAPHY; MASS SCREENING; PREVALENCE; RISK FACTORS;

EID: 0034760156     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200111000-00002     Document Type: Review

References (56)

1. Estimates of the worldwide incidence of 25 major cancers in 1990
2. Global breast cancer mortality statistics
3. Cancer statistics 2000
4. Prevalence of Klinefelter's syndrome in male breast cancer patients
5. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population
6. BRCA2 germline mutations in male breast cancer cases and breast cancer families
7. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13
8. The genetic epidemiology of male breast cancer
9. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk
10. Dual effects of weight and weight gain on breast cancer risk
11. Weight change and risk of postmenopausal breast cancer (United States)
12. Physical activity and the risk of breast cancer
13. Breast cancer among former college athletes compared to non-athletes: A 15-year follow-up
14. Physical activity and risk of breast cancer in the Framingham Heart Study
15. Life-long physical activity and cancer risk among Finnish female teachers
16. Physical activity and breast cancer risk in women aged 20-54 years
17. The effect of physical activity on breast cancer risk: A cohort study of 30,548 women
18. Age at any birth is associated with breast cancer risk
19. Age at any full-term pregnancy and breast cancer risk
20. Cohort studies of fat intake and the risk of breast cancer: A pooled analysis
21. Types of dietary fat and breast cancer: A pooled analysis of cohort studies
22. Meta-analysis of studies on breast cancer risk and diet: The role of fruit and vegetable consumption and the intake of associated micronutrients
23. Intake of fruits and vegetables and risk of breast cancer: A pooled analysis of cohort studies
24. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer
25. Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: Results from a prospective study in Columbia, Missouri
26. Serum carotenoids and breast cancer
27. A prospective study of folate intake and the risk of breast cancer
28. Dietary folate consumption and breast cancer risk
29. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women
30. Serum hormones and the alcohol-breast cancer association in postmenopausal women
31. Alcohol consumption and risk of breast cancer: A multicentre Italian case-control study
32. Alcohol and breast cancer in women: A pooled analysis of cohort studies
33. Breast cancer and hormonal contraceptives: Collaborative analysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies
34. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer
35. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
36. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
37. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
38. Risk factors for breast cancer in women with proliferative breast disease
39. Benign breast changes and the risk for subsequent breast cancer: An update of the 1985 consensus statement
40. Effects of mammographic density and benign breast disease on breast cancer risk (United States)
41. Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Reference Pathologists of the Canadian National Breast Screening Study
42. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic
43. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
44. Tamoxifen and breast cancer incidence among women with BRCA1 or BRCA2 mutations: A genomics resequencing project embedded in the breast cancer prevention trial
45. Reduction in breast cancer risk following bilateral prophylactic oophorectomy in BRCA1 mutation carriers
46. Prophyractic oophorectomy in BRCA1 and BRCA2 mutation carriers
47. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
48. Breast cancer after prophyractic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation
49. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
50. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
51. Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women - Italian Tamoxifen Prevention Study
52. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-Year results from the MORE trial: Multiple Outcomes of Raloxifene Evaluation
53. Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998
54. Canadian National Breast Screening Study 2: 13-Year results of a randomized trial in women aged 50-59 years
55. Breast density as a predictor of mammographic detection: Comparison of interval- and screen-detected cancers
56. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer